Kenvue Inc. $KVUE Shares Acquired by Bessemer Group Inc.

Bessemer Group Inc. increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 0.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 8,525,023 shares of the company’s stock after buying an additional 33,680 shares during the period. Bessemer Group Inc.’s holdings in Kenvue were worth $146,972,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Kenvue by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 234,951,484 shares of the company’s stock valued at $4,052,913,000 after buying an additional 1,604,040 shares during the last quarter. State Street Corp increased its position in shares of Kenvue by 3.5% during the fourth quarter. State Street Corp now owns 118,865,134 shares of the company’s stock worth $2,050,424,000 after acquiring an additional 4,063,257 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Kenvue by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company’s stock worth $856,778,000 after acquiring an additional 371,322 shares in the last quarter. Independent Franchise Partners LLP lifted its stake in shares of Kenvue by 56.3% in the fourth quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company’s stock worth $830,527,000 after acquiring an additional 17,343,785 shares in the last quarter. Finally, Norges Bank purchased a new position in Kenvue in the fourth quarter valued at about $756,862,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the subject of a number of recent analyst reports. Citigroup lowered their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Barclays reduced their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a research note on Sunday, July 12th. Finally, Zacks Research cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus price target of $19.50.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.59% of the stock is owned by company insiders.

Kenvue Stock Up 1.8%

NYSE:KVUE opened at $19.03 on Friday. The company has a market capitalization of $36.55 billion, a price-to-earnings ratio of 22.39, a price-to-earnings-growth ratio of 1.42 and a beta of 0.47. Kenvue Inc. has a one year low of $14.02 and a one year high of $22.87. The stock has a 50-day simple moving average of $18.17 and a 200 day simple moving average of $17.85. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. During the same period in the previous year, the company earned $0.24 earnings per share. Kenvue’s quarterly revenue was up 4.5% on a year-over-year basis. Sell-side analysts predict that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio is currently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.